Contract Research Collaborations (CRC)
Boost your drug discovery project with high quality molecular interaction data! Biophysical characterization by Biacore SPR in a fee-for-service model with quick turn-around times.
Since 2006, our well experienced team delivers e.g. affinity and kinetic characterization profiles as well as mechanistic evaluation insights for a wide range of different protein drug target types and purposes:
- Small molecule protein interaction analysis, including fragment based drug discovery
- Protein protein interaction analysis, e.g. for PPI screening purposes
- Antibody interaction analysis
- Deconvolution of binding mode and site
- Identification of allosteric binders
Examples of non-confidential clients and partners include Boehringer Ingelheim, Janssen Pharmaceutical Companies of Johnson & Johnson, Sanofi, Almac Discovery Ltd. and Medivir. Our quick project turn-around time and detailed reporting has been appreciated by many customers (see customer quotes).
Beactica's drug discovery platform is based on state-of-the-art Biacore surface plasmon resonance (SPR) biosensor technology. It is augmented by proprietary methodology, algorithms, and experimental designs. We are continuously sharpening our tools to deliver scientific excellence. As a result, new tools have been developed, advancing the outer detection limits of the technology:
Beactica operates a flexible business model with opportunities for FTE, fee-for-service, results-based deals and partnerships. Solutions are tailored based on the customer/partner/project needs.
Ask us how we can be your research asset in early and late stages of pre-clinical drug discovery – hit or lead discovery as well as lead optimization.